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CORRESPONDENCE
Pseudomonas oryzihabitans peritonitis in a
patient on continuous ambulatory peritoneal
dialysis
Pseudomonas oryzihabitans is a non-fermentative,
Gram-negative bacterium that has been implicated
in human pathology, mainly as an agent of cathe-
ter-related bacteremia [1–3]. Recent data suggest
that environmental sources may be implicated in
the pathogenesis of infection due to this species [4],
as well as the presence of catheters and other for-
eign bodies [3]. We report a case of peritonitis due
to P. oryzihabitans in a patient undergoing contin-
uous ambulatory peritoneal dialysis (CAPD), and
review the cases of peritonitis due to this organism.
C A S E S U M M A R Y
The patient was a 50-year-old woman with mesan-
gial immunoglobulin A (IgA) nephropathy; she
had started CAPD in November 1997. Her past
history included hypertension, obesity, hyperch-
olesterolaemia and glucose intolerance. She had a
peritonitis due to Pseudomonas aeruginosa in June
1998, as well as several exit-site infections due to
Escherichia coli during 1999 and 2000.
In January 2001, she complained of perium-
bilical pain. Physical examination disclosed peri-
umbilical erythema, warmth and swelling. The
peritoneal fluid leucocyte count was 100 cells/mL
with 85% mononuclear cells. Oral cefuroxime,
500 mg twice daily was prescribed. Forty-eight
hours later the patient complained of abdominal
pain and cloudy effluent. The peritoneal effluent
cell count was 2400 cells/mL (90% neutrophils).
An abdominal ultrasound showed a periumbilical
abscess 2 cm in diameter, not communicating with
the peritoneal cavity or the catheter tunnel. Emp-
irical treatment with intraperitoneal gentamicin
(50 mg once daily) and vancomycin (2 g/week)
was prescribed and peritoneal effluent was sent
for culture.
The peritoneal effluent was processed according
to the usual techniques [5]. A Gram stain showed
abundant polymorphonuclear leucocytes but no
bacteria. After 48 h of incubation, there was scanty
colony growth on aerobic media (Tryptic soy
blood agar and chocolate agar) and in the aerobic
bottle of liquid media. The colonies were yellow
and wrinkled. The Kovacs oxidase test was nega-
tive and the organism was finally identified as P.
oryzihabitans, using an API-20 NE strip (code no.
00476151). The strain was susceptible to third- and
fourth-generation cephalosporins, carbapenems,
aminoglycosides, piperacillin/tazobactam and cip-
rofloxacin, and was resistant to ampicillin, cefazo-
lin and cefuroxime. Vancomycin treatment was
suspended, and gentamicin and cefuroxime were
continued for 2 and 3 weeks, respectively. The
response was satisfactory.
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Table 1 Characteristics of patients with Pseudomonas oryzihabitans peritonitis and peritoneal dialysis
Case Ref. Sex Age Underlying diseases Therapy
Previous episodes of
dialysis-related
infection (organism) Outcome
1 [10] M 54 Diabetes, chronic
glomerulonephritis.
CAPD
Cefazolinþ tobramycin,
tobramycin
Yes (Acinetobacter
calcoaceticus var.
anitratus, Escherichia coli)
Cure
2 [7] M 62 Obstructive uropathy.
CAPD
Cefuroximeþ gentamicin,
gentamicin
Yes (Coagulase-negative
Staphylococcus)
Cure
3 [8] M 47 Goodpasture’s syndrome.
CAPD
Cephapirinþ gentamicin,
ampicillin
Yes (Coagulase-negative
Staphylococcus)
Cure
4 [2] M 63 Diabetes. CAPD Vancomycinþ tobramycin,
tobramycin
Yes (Staphylococcus
aureus)
Cure
5 [9] F 44 Heart/lung transplant.
CCPDa
Vancomycinþ tobramycin,
tobramycin
Yes (Staphylococcus
aureus, Coagulase-
negative
Staphylococcus)
Cure
6 This F 50 Mesangial IgA Gentamicinþvancomycin, Yes (Pseudomonas Cure
case nephropathy.
CAPD
gentamicinþ cefuroxime aeruginosa,
Escherichia coli)
aCCPD, continuous cycling peritoneal dialysis.
Pseudomonas oryzihabitans has recently been re-
classified in the genus Pseudomonas [6]. It is an
inhabitant of soil and moist environments, which
has been suggested as a source of human infection
[3,4]. We reviewed the medline database and
found only five previous reports of CAPD-related
peritonitis [2,7–9], although another two cases
have also been described [1,3]. However, in these
two cases, the isolate was not in pure culture, so its
pathogenic role in the disease is not certain. Peri-
toneal dialysis-related cases are summarized in
Table 1 [2,7–9]. As in the case described here, all
other patients had a history of infections related to
the dialysis procedure, although the organisms
implicated in these earlier episodes were different.
Therapy differed, but aminoglycosides were in-
cluded as empirical therapy in all cases. No cathe-
ters were removed, and all the patients were cured
with antimicrobial therapy alone.
In conclusion, the isolation of this environmen-
tal organism in clinical samples must be inter-
preted according to clinical data, as they can be
the cause of disease in immunocompromised hosts
or in those with indwelling devices such as peri-
toneal catheters. Given the low virulence of the
organism, antibiotics alone should be able to clear
the infection: however, removal of indwelling
catheter(s) may be required.
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